In 1993 the North London Blood Transfusion Centre received its first r
eport of Yersinia enterocolitica transmission from a unit of red cells
supplied to a local hospital. The recipient was a 23-year-old male wh
o was neutropenic following a third cycle of chemotherapy for treatmen
t of acute myeloblastic leukaemia (FAB type M6) and received a 34-day-
old red cell unit. During transfusion the patient developed septicaemi
a and endotoxin-mediated shock. The transfusion was stopped immediatel
y and broad spectrum antibiotics administered immediately on suspicion
of bacteraemia from the transfused unit. This prompt action undoubted
ly prevented a fatal outcome. Y. enterocolitica was isolated from the
blood bag. Antibody was also detected in the bag and in a sample taken
from the donor 39 days post-donation. Antibody to serotype 03 was ide
ntified, the commonest serotype reported in transfusion-transmitted Y.
enterocolitica. The donor reported no gastrointestinal upset or illne
ss prior to donation. This transfusion reaction might not have occurre
d had the red cells been transfused earlier in their storage period, b
ut would not have been prevented by the exclusion of donors with a his
tory of gastrointestinal illness as the donor was asymptomatic. Nor wo
uld it have been prevented by inspecting the blood for a change in col
our, as no such change was observed. Y. enterocolitica is a significan
t problem in transfusion medicine and transmission is generally associ
ated with a high mortality rate. Hospitals should be urged to investig
ate bacteriologically all appropriate transfusion reactions so that th
e true extent of the problem in the United Kingdom can be assessed.